National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer

AstraZeneca1 site in 1 country1,500 target enrollmentJune 2007

ConditionsInfiltrative Breast Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Infiltrative Breast Cancer
Sponsor: AstraZeneca
Enrollment: 1500
Locations: 1
Primary Endpoint: Radiological, Clinical and Histological characteristics
Status: Completed
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.

Registry

clinicaltrials.gov

Start Date

June 2007

End Date

July 2008

Last Updated

15 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

AstraZeneca

Eligibility Criteria

Inclusion Criteria

•Women\> or = 18 years old
•Women with newly diagnosis of infiltrative breast cancer
•Agree to take part in this study

Exclusion Criteria

•Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
•Women with in situ ductal carcinoma or in situ lobular carcinoma